CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress

Published:2022-03-24 Issue:6 Volume:31 Page:593-605
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Corti Chiara¹²^ORCID,Venetis Konstantinos²^ORCID,Sajjadi Elham²^ORCID,Zattoni Lorenzo²^ORCID,Curigliano Giuseppe¹²^ORCID,Fusco Nicola²³^ORCID

Affiliation:

1. Division of New Drugs and Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy

2. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy

3. Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2022.2054326

Reference124 articles.

1. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

2.

Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options

3. PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

4. Managing side effects of immune checkpoint inhibitors in breast cancer

5. Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12

2. Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment;Cancer Drug Resistance;2024-09-13

3. The potential role of CD8+ cytotoxic T lymphocytes and one branch connected with tissue-resident memory in non-luminal breast cancer;PeerJ;2024-07-10

4. Immunotherapy in Breast Cancer;International Journal of Molecular Sciences;2024-07-09

5. The therapeutic role of γδT cells in TNBC;Frontiers in Immunology;2024-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3